Updated on 8 October 2026
Collaboration in research projects
CEO-Co-founder at Aequilibria Health
Rome, Italy
About
Open to research and clinical collaborations to include our innovative digital neurotherapy app, Frequentia, designed to bring laboratory-grade 40 Hz gamma brainwave entrainment directly to consumers and patients via smartphones.
By combining multisensory controlled stimulation, Frequentia non-invasively stimulates 40 Hz gamma oscillations in the brain. Gamma brainwaves are critical for executive function, memory processing, and neural synchronization.
Rather than replacing primary care protocols, Frequentia is designed to run in parallel with standard-of-care pharmacotherapies, lifestyle interventions, or cognitive rehabilitation programs—offering an accessible, home-based digital therapeutic tool.
Ideal Study Areas & Target Applications
-
Neurodegenerative & Memory Studies: Investigating the impact of 40 Hz gamma entrainment on early-stage cognitive decline or subjective cognitive complaints.
-
Stress, Burnout & Executive Function: Assessing cognitive resilience, fatigue recovery, and daily focus in high-stress populations or healthy aging cohorts.
-
Sleep & Circadian Rhythms: Evaluating multisensory entrainment effects on sleep quality, mood regulation, and autonomic function.
Type
- Market Access
- Strategic Partnership
- Technological contribution
Similar opportunities
Product
Frequentia: Digital Neurotherapy for Brain Longevity
- Buyer
- License partner
- Investment/Finance
- Re-Seller/Wholesaler
- Demonstration / Pilot projects
Emanuela Russo
CEO-Co-founder at Aequilibria Health
Rome, Italy
Partnership
- Research
- Business
- Joint development
- Testing of technology
Emanuela Russo
CEO-Co-founder at Aequilibria Health
Rome, Italy
Investment
Investment opportunities in brain health and longevity
- Seed funding | Get business started
Emanuela Russo
CEO-Co-founder at Aequilibria Health
Rome, Italy